COHORT ANALYSIS ASSESSING MEDICAL AND NON-MEDICAL COST ASSOCIATED WITH OBESITY IN THE WORKPLACE
Author(s)
Abouzaid S*1;Kleinman NL2;Andersen L3;Wang Z1, Powers A1 1Eisai Inc., Woodcliff Lake, NJ, USA, 2The HCMS Group, Cheyenne, WY, USA, 3HCMS Group, Cheyenne, WY, USA
Presentation Documents
OBJECTIVES: Overweight and obesity are a growing epidemic in the US, affecting more than two-thirds of working-age adults. This study quantifies the economic burden associated with obesity from the employer’s perspective, including employee medical, drug, sick leave (SL), short- and long-term disability (STD; LTD), and workers’ compensation (WC) costs, work absence days, and self-reported productivity. METHODS: Using a retrospective database from large employers throughout the US, employees’ body mass index (BMI) values (widely used for categorizing obesity) from 2003-2011 health risk appraisal data were used to create 3 cohorts: BMI<27, 27
Conference/Value in Health Info
2013-05, ISPOR 2013, New Orleans, LA, USA
Value in Health, Vol. 16, No. 3 (May 2013)
Code
DU3
Topic
Economic Evaluation
Topic Subcategory
Budget Impact Analysis
Disease
Diabetes/Endocrine/Metabolic Disorders